Ankylosing Spondylitis is a type of arthritis condition that causes stiffness in the spine and can result in forward head posture (FHP)
![]() |
| Ankylosing Spondylitis |
People who have ankylosing
spondylitis must accept many changes in their lives, including rearranging
their relationships, altering their work habits, and changing their leisure
activities. In addition, they must deal with the appearance of their legs and heels,
which can make standing uncomfortable. For
instance, in April 2022, AbbVie, a major biopharmaceutical firm in the U.S.,
reported the results of its SELECT-PsA 2 study, concluding that Upadacitinib
can effectively reduce ankylosing spondylitis pain within one year.
According
to Coherent Market Insights, The global Ankylosing Spondylitis Market
is estimated to be valued at US$ 4,864.3 million in 2021 and is expected to
exhibit a CAGR of 8.2% during the forecast period (2021-2028).
Ankylosing spondylitis is an
inflammatory condition that affects the spine. The disease causes the ligaments
and joints that allow the spine to move to become stiff and inflamed.
Eventually, this results in the fusion of bones and vertebrae, which may affect
breathing and posture. The symptoms of ankylosing spondylitis can range from
low back pain to hip pain, neck pain, and fatigue. These symptoms can worsen at
irregular intervals. They can be worse in the morning or after a nap. Occasionally,
a red eye may occur. In severe cases, vision loss may occur.
Nonsteroidal anti-inflammatory drugs
(NSAIDs) are commonly used as a treatment for ankylosing spondylitis. NSAIDs
provide relief from the inflammation and pain of the disease, and are generally effective in reducing pain and
stiffness. Other medications, such as IL-17 inhibitors and TNFa blockers, may
also be prescribed. However, the use of
these drugs in Ankylosing
Spondylitis should only be attempted with the supervision of a
physician.
Biologics are being studied as
potential treatments for ankylosing spondylitis. These are genetically
engineered proteins that target tumor necrosis factor, which causes
inflammation and damage in joints. These biologics have several advantages and
drawbacks. They may be more expensive than conventional treatments and have a
higher risk of serious health complications.

Comments
Post a Comment